Free Trial
→ Financial legend: “This is bad, really bad...” (From Weiss Ratings) (Ad)tc pixel
OTCMKTS:OTSKY

Otsuka Q1 2026 Earnings Results & Report

Otsuka logo
$38.64 +0.50 (+1.32%)
As of 03:53 PM Eastern

Otsuka beat analyst expectations on both earnings and revenue in its Q1 2026 results, released April 28, 2026. The company reported EPS of $0.59 versus the $0.4306 consensus estimate, while revenue of $3.96 billion topped the $3.78 billion estimate by $182.52 million.

Research:ProfileEarnings HistoryForecast

Earnings Announcement Details

Quarter
Q1 2026
Report Date
Time
Before Market Opens

Otsuka EPS Results

Actual EPS
$0.59
Consensus EPS
$0.4306
Beat/Miss
Beat by +$0.1594
One Year Ago EPS
N/A

Otsuka Revenue Results

Actual Revenue
$3.96 billion
Expected Revenue
$3.78 billion
Beat/Miss
Beat by +$182.52 million
YoY Revenue Growth
N/A

Upcoming Earnings

Otsuka's next earnings date is estimated for Friday, October 30, 2026, based on past reporting schedules.

Conference Call Resources

Otsuka Q1 2026 Earnings FAQ

Otsuka (OTCMKTS:OTSKY) reported earnings of $0.59 per share for Q1 2026, beating the consensus estimate of $0.4306. The report was announced on Tuesday, April 28, 2026.

Otsuka reported revenue of $3.96 billion for Q1 2026, against a consensus estimate of $3.78 billion.

Otsuka's next earnings date is estimated for Friday, October 30, 2026. MarketBeat tracks confirmed and estimated earnings dates for Otsuka on the company's earnings history page.

Otsuka Earnings Headlines

Otsuka (OTCMKTS:OTSKY) Shares Gap Down - Here's Why
October 12, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31111207
Dr. Reddy's Laboratories (NYSE:RDY) & Otsuka (OTCMKTS:OTSKY) Head to Head Review
October 8, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31099018
Elon Musk’s 4th Wealth Window Set to Open by October 30
Jeff Brown, the analyst who flagged Bitcoin, Tesla, and Nvidia early, is tracking Elon Musk's next move. He points to a new AI project tied to Musk's Cybercab reveal. Brown says Musk has opened major investment windows before, with PayPal, Tesla, and SpaceX marking milestones in tech history. He believes a fourth may open by October 30.tc pixel
October 16 at 1:00 AM  |  Brownstone Research (Ad)
Otsuka Holdings Co., Ltd. (OTSKY) Discusses 24-Month eGFR Results of Sibeprenlimab in IgA Nephropathy from Phase III VISIONARY Study Prepared Remarks Transcript
August 6, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4931746-otsuka-holdings-co-ltd-otsky-discusses-24-month-egfr-results-of-sibeprenlimab-in-iga
Otsuka Holdings Co (OTSKF) Gets a Buy from Bank of America Securities
July 25, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/OTSKY/pressreleases/3445304/otsuka-holdings-co-otskf-gets-a-buy-from-bank-of-america-securities/
Analysts Are Bullish on These Healthcare Stocks: Arrowhead Pharmaceuticals (ARWR), Otsuka Holdings Co (OTSKY)
July 25, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/OTSKY/pressreleases/3429352/analysts-are-bullish-on-these-healthcare-stocks-arrowhead-pharmaceuticals-arwr-otsuka-holdings-co-otsky/
See More Otsuka Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Otsuka? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Otsuka and other key companies, straight to your email.

About Otsuka

Otsuka (OTCMKTS:OTSKY) Holdings Co., Ltd. is a Japan-based healthcare company that oversees the Otsuka Group’s pharmaceutical, nutraceutical and consumer health businesses. The company’s operations are primarily conducted through subsidiaries, including Otsuka Pharmaceutical Co., Ltd., which researches, develops, manufactures and markets prescription medicines, over-the-counter products and health-related foods.

Otsuka’s pharmaceutical activities focus on areas such as psychiatry, oncology, cardiovascular and renal medicine, and several other specialized therapeutic fields. Its nutraceutical and consumer health businesses offer products designed to support hydration, nutrition and general wellness, including the Pocari Sweat and Oronamin C brands in select markets. The group also has activities in medical devices and other health-related businesses.

Otsuka Holdings was established in 2008 as the holding company for the Otsuka Group and was listed on the Tokyo Stock Exchange in 2010. The group serves customers in Japan and international markets through research, manufacturing and commercial operations across North America, Europe, Asia and other regions. Tatsuo Higuchi serves as president and chief executive officer of Otsuka Holdings.

View Otsuka Profile
Earnings Tools